面部异体植入物手术的早期结局与并发症危险因素:一项ACS-NSQIP研究
研究基于ACS-NSQIP数据库(2008-2021)纳入84例接受颧骨/下颌区域异体植入物手术的患者,分析早期结局与并发症危险因素。结果显示联合手术和下颌骨增强术患者更可能出现并发症或需要住院,而单纯颧骨和下颌骨异体植入总体安全。大多数下颌骨或颧骨异体植入为联合其他手术(62%),提示在学术环境中常作为复杂颅颌面疾病治疗的辅助手段。
要点
- 联合颧骨和联合下颌骨手术并发症率最高(16%和15%),单纯颧骨和单纯下颌骨手术并发症率较低(10%和4.5%)。
- 单纯颧骨手术患者中活动性吸烟者达60%,单纯下颌骨手术患者中高血压者达41%。
- 大多数下颌骨或颧骨异体植入为联合其他手术(62%),常作为复杂颅颌面疾病治疗的辅助手段。
核心结论
- 在ACS-NSQIP数据库中,颧骨和下颌骨异体增强术总体安全。
- 接受联合手术和下颌骨增强术的患者更可能出现并发症或需要住院。
- 大多数下颌骨或颧骨异体增强术为联合其他手术(62%),提示在学术环境中常作为复杂颅颌面疾病治疗的辅助手段。
研究设计与样本
- 查询ACS-NSQIP数据库(2008-2021),识别接受颧骨/下颌区域联合或单纯异体植入物手术的患者。
- 根据CPT编码(21125;21270)将手术分为颧骨联合、颧骨单纯、下颌骨联合、下颌骨单纯异体植入物手术。
- 研究人群共84例患者。
主要发现
- 研究人群84例中,联合颧骨手术19例(23%),单纯颧骨手术10例(12%),联合下颌骨手术33例(39%),单纯下颌骨手术22例(26%)。
- 单纯颧骨手术(共10例)患者中活动性吸烟者达6例(60%),单纯下颌骨手术(共22例)患者中高血压者达9例(41%)。
- 联合颧骨手术(19例)和联合下颌骨手术(33例)并发症率最高,分别有3例(16%)和5例(15%)患者发生任何并发症。
- 对于单纯颧骨和单纯下颌骨手术,分别有1例(10%和4.5%)患者报告任何并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Facial implantology (FI) is a growing field in facial surgery that focuses on harmonizing and balancing facial features. Despite its increasing popularity, larger-scale studies on FI outcomes and risks are scarce. METHODS: The ACS-NSQIP (2008-2021) was queried to identify patients who underwent combined/isolated alloplastic FI surgery of the malar/mandibular region. Based on CPT codes (21125; 21270), procedures were subdivided into combined or isolated FI surgery of the malar or the mandibular region. RESULTS: The study population included 84 patients, of which n = 19 (23%), n = 10 (12%), n = 33 (39%), and n = 22 (26%) underwent combined malar, isolated malar, combined mandibular, and isolated mandibular FI surgery, respectively. Isolated malar (total n = 10) and mandibular FI surgery (total n = 22) patients had relatively high comorbidity rates with up to n = 6 (60%) active smokers and n = 9 (41%) with hypertension, respectively. Combined malar (n = 19) and mandibular FI surgeries (n = 33) had the highest complication rates with n = 3 (16%) and n = 5 (15%) patients experiencing any complications. For both isolated malar and mandibular FI procedures, n = 1 (10% and 4.5%) patient reported any complications. CONCLUSION: In this study, we accessed the ACS-NSQIP database and found alloplastic augmentation for zygoma and mandible to be safe. Patients who underwent combined procedures and mandibular augmentation were more likely to show complications or require inpatient stay. Most alloplastic augmentations of mandible or zygoma were combined with other procedures (62%) which suggests that alloplastic facial implants (in the academic setting) are often used as an adjunct in the treatment of complex craniofacial disorders.
引用
- Kauke-Navarro M, Knoedler L, Deniz C, et al. Early outcomes and risk factors for complications after facial alloplastic implant surgery: An ACS-NSQIP study. J Plast Reconstr Aesthet Surg. 2024. PMID: 38387417. doi:10.1016/j.bjps.2024.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。